May 12, 2022 Clinical Research Study finds a way forward for potential new treatments as gene that causes Lupus has been discovered.
February 7, 2022 Cancer/Oncology Case studies reported in Nature of decade-long leukaemia remissions after CAR T treatment. #GoScience
September 20, 2021 Genomics Two-year cancer-DNA-fragment screening blood test trial to start in England to assess sensitivity and specificity of early detection of numerous cancer types. If successful, it could lead to treatment of once difficult-to-detect early cancers.
August 23, 2021 Allergy/Immunology AstraZeneca is soon to publish results from its pre-exposure prophylaxis trial about anti-Covid antibodies given IM to people with comorbid states that reduce the immune response from vaccines. Reduced severe symptomatic risk (relative) by 77%.
March 10, 2021 Allergy/Immunology New T-cell test to determine past exposure to SARS-CoV-2 is cool science but not a game changer. It may help answer why some become long-haulers after infection while others do not and it is a starting point for discovery and treatment research.
February 3, 2021 Bioengineering Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.
September 3, 2020 Epidemiology Excellent application of science as supercomputer genetic analysis generates plausible hypothesis that unifies the disparate Covid-19 symptoms into a coherent whole. Clinical studies required to prove the claim.
May 22, 2020 Clinical Research Is this hypothesis the ACE in the hole that explains why children account for so few cases of SARS-CoV-2? Verification and further evaluation required.
May 6, 2020 Epidemiology Los Alamos Lab uses computational analysis of 6000 coronavirus sequences to conclude that a mutated strain is now dominant. Clinical implications remain unknown and study needs to be peer -reviewed and published.